Identification of macrocyclic peptides which activate bacterial cylindrical proteases

Area of Science:

• Biochemistry
• Molecular Biology
• Drug Discovery

Background:

• The caseinolytic protease complex ClpXP is essential in prokaryotes for degrading misfolded proteins and regulating cellular processes.
• Targeting ClpP, the proteolytic core of ClpXP, is a promising strategy for combating bacterial infections and reducing virulence.

Purpose of the Study:

• To identify novel macrocyclic peptides that activate ClpP-mediated proteolysis using a rational drug-design approach.
• To gain insights into ClpP dynamics and the influence of its binding partner, ClpX, on its conformation.

Main Methods:

• Employed a rational drug-design strategy to discover ClpP-activating compounds.
• Utilized chemical approaches to investigate ClpP dynamics and ClpX-mediated conformational control.

Main Results:

• Identified specific macrocyclic peptide ligands that enhance ClpP proteolytic activity.
• Elucidated aspects of ClpP conformational changes influenced by its interaction with ClpX.

Conclusions:

• Macrocyclic peptides represent a potential starting point for developing novel ClpP activators.
• This research advances the understanding of ClpP function and its regulation by ClpX, paving the way for new antibacterial therapies.